Clinical Trial Update: A Phase 2 Study of CIN-102 in Adults With Idiopathic and Diabetic Gastroparesis [Phase 2]

View source ↗

Summary

A Phase 2 study of CIN-102 for idiopathic and diabetic gastroparesis was terminated, and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Gastroparesis
• Idiopathic Gastroparesis

Drugs mentioned

• CIN-102

Snippet

Sponsor: CinDome Pharma, Inc. | Conditions: Gastroparesis | Phase 2 | Status: TERMINATED | Results posted: 2026-03-25